Heart failure patients get Dual-Drug hope
NCT ID NCT06520891
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing whether taking a statin (atorvastatin) together with an SGLT2 inhibitor (dapagliflozin) helps people with ischemic heart failure. Researchers will measure cholesterol levels and other lab tests in 90 participants. The goal is to see if the combination works better than either drug alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atorvastatin (statin) and dapagliflozin (SGLT2i)
What this could lead to
If it works, this could show that taking both drugs together helps manage cholesterol and heart health better than either alone.
What could go wrong
This is a small, early-phase study with only 90 participants, so results may not apply to everyone. The trial focuses on lab tests, not long-term outcomes like survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asmaa mohamed abdelkader
RECRUITINGAl Fayyum, Faiyum Governorate, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••